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The burgeoning field of epigenetics is beginning to make a significant impact on our
understanding of tissue development, maintenance, and function. Epigenetic mechanisms
regulate the structure and activity of the genome in response to intracellular and
environmental cues that direct cell-type specific gene networks. The inner ear is comprised
of highly specialized cell types with identical genomes that originate from a single
totipotent zygote. During inner ear development specific combinations of transcription
factors and epigenetic modifiers must function in a coordinated manner to establish
and maintain cellular identity. These epigenetic regulatory mechanisms contribute to the
maintenance of distinct chromatin states and cell-type specific gene expression patterns.
In this review, we highlight emerging paradigms for epigenetic modifications related to
inner ear development, and how epigenetics may have a significant role in hearing loss,
protection, and regeneration.
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INTRODUCTION
In 1942, C. H. Waddington coined the term epigenetics by com-
bining the words epigenesis and genetics (Waddington, 2012).
Epigenesis refers to the sequence of events that occur during
differentiation of cells from their initial totipotent state to a fully
developed multicellular organism. The physical nature of genes
and their role in heredity was unknown at the time Wadding-
ton coined this term. However, he used the term epigenetics
to refer to the increasing irreversibility of cellular differenti-
ation as a cell becomes more differentiated during develop-
ment. The field of developmental biology continues striving to
better understand how a single totipotent cell containing one
genome has the ability to generate millions of highly special-
ized fully differentiated cells with very different gene regulatory
networks.
The definition of epigenetics has evolved over the years
and continues to be debated by scientists. Epigenetics was
classically defined as heritable changes in gene function that
cannot be explained by changes in DNA sequence and
typically referred to DNA methylation related to parental
genomic imprinting. However, this definition has changed dras-
tically in recent years to encompass non-heritable changes
that alter gene function including dynamic chromatin states
regulated by various histone modifications and chromatin
remodeling proteins. The development of the “omics era”
has greatly impacted the way scientists now view epigenet-
ics since many human developmental disorders and cancer
have been correlated with the misregulation of specific epi-
genetic events and has driven the development of epigenetic
therapeutics.
Although a vast amount of data about epigenetics exists for
other tissues, there is a noticeable lack of information about
epigenetic modifications in the inner ear. Proper epigenetic mod-
ifications are required for normal developmental processes. Gene
expression must be coordinated in a temporal and cell-type
specific manner and requires multiple levels of gene regulation.
Although transcription factors are a primary source of gene
regulation, epigenetic modifications regulate transcription factor
access to target genes. This concept is apparent from studies
looking at direct cellular reprogramming through ectopic expres-
sion of defined transcription factors, which show that direct
reprogramming is a slow and inefficient process with most cells
failing to reprogram (Huangfu et al., 2008; Mikkelsen et al., 2008).
In the auditory field, ectopic expression of transcription factors
such as Atoh1 has been used to convert mammalian non-sensory
epithelial cells into cells that express many endogenous hair cell
markers (Zheng and Gao, 2000; Izumikawa et al., 2005; Gubbels
et al., 2008). However, the reprogramming process of transform-
ing supporting cells into hair cells may not be solely about genetic
transformation, but also epigenetic transformation. Studies using
induced pluripotent stem cells (iPSCs) have shown that they
retain the epigenetic memory of their somatic cell of origin (Kim
et al., 2010; Lister et al., 2011). The epigenetic memory retained
by iPSCs can interfere with their potential for differentiation
into other cell types (Li et al., 2009; Kim et al., 2010; Lister
et al., 2011). Additionally, iPSCs derived from aged mice have
a decreased potential for reprogramming compared to iPSCs
derived from juvenile mice (Li et al., 2009; Lister et al., 2011).
Although ectopic expression of transcription factors (Atoh1) can
convert neonatal non-sensory epithelial cells into hair cell-like
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cells, loss of cellular plasticity at later postnatal ages could largely
impact clinical application of this method (Kelly et al., 2012; Liu
et al., 2012b).
In this review, we discuss the different types of epigenetic mod-
ifications and regulatory mechanisms in regards to development,
disease, protection, and cellular reprogramming.
HISTONE MODIFICATIONS
Nucleosomes form the fundamental repeating units of eukary-
otic chromatin, which is used to package large eukaryotic
genomes into the nucleus while still ensuring appropriate access
to the chromatin (Kornberg, 1974; Kornberg and Thomas,
1974). Nucleosomes are folded through a series of succes-
sively higher order structures to both compact DNA and
create an added layer of regulatory control ensuring correct
gene expression. The nucleosome is comprised of approxi-
mately 147 base pairs of DNA wrapped around eight histone
core subunits consisting of two copies each of the core his-
tones H2A, H2B, H3, and H4 (Luger et al., 1997). Histone
H3 and H4 have long tails that protrude from the nucleo-
some and can be covalently modified at several sites (Figure 1;
Vaquero et al., 2003; Campos and Reinberg, 2009; Bannister
and Kouzarides, 2011). These histone tails are subjected to
post-translational modification including acetylation, methyla-
tion, phosphorylation, ubiquitination, sumoylation, or ADP-
ribosylation which is mediated by the counteracting activities of
enzymes that add or remove such modifications (Vaquero et al.,
2003; Campos and Reinberg, 2009; Bannister and Kouzarides,
2011).
HISTONE ACETYLATION
Posttranslational histone modifications alter histones interaction
with DNA and nuclear proteins. Histone acetylation of specific
lysine residues plays a fundamental role in transcriptional regu-
lation. The enzymes responsible for maintaining proper histone
acetylation states include histone acetyltransferases (HATs) and
histone deacetylases (HDACs). Histones undergo acetylation
to yield a more relaxed chromatin conformation resulting
from a net change in the overall charge and reduced elec-
trostatic interactions. HATs transfer the acetyl moiety from
acetyl coenzyme A to specific lysine residues on the his-
tone tail. Acetylated histones also act as a signal that recruits
bromodomain-containing proteins, which are primarily tran-
scription factors and cofactors to target genes activating their
transcription (Zeng and Zhou, 2002). The HDACs act in oppo-
sition to the HATs by removing the acetyl groups from his-
tone tails allowing histones to interact with DNA more tightly
to form a compacted nucleosome structure. This increased
rigidity of the chromatin prevents the incorporation of tran-
scriptional machinery, effectively silencing gene transcription
(Figure 2).
HISTONE METHYLATION AND DEMETHYLATION
Histone methylation, depending on both the histone and residue
modified, contributes to either active or repressive chromatin
configurations (Figure 2). Although histone methylation is not
as well understood as acetylation, histones H3 and H4 are com-
mon methylation targets that can be methylated on arginine
and lysine residues (Figure 1). While lysine can receive only
one acetyl group, it can receive up to three methyl groups, and
does not affect the overall charge of the residue. Specific histone
methylation states serve as binding sites for the recruitment
of additional regulatory proteins such as chromatin remodel-
ers (Zhang and Dent, 2005; Wu and Zhang, 2009; Helin and
Dhanak, 2013). As a general rule of thumb, sites of methylation
that are typically associated with active gene transcription are
H3K4me2/3 (promoter), H3K36me3 (3′ end gene body), and
H3K79me2 (5′ end of gene body) (Azuara et al., 2006; Kolasinska-
Zwierz et al., 2009; Onder et al., 2012; Fuchs et al., 2014).
Whereas methylation marks associated typically with silenced
FIGURE 1 | Cartoon diagram indicates potential sites of modification
at specific residues along the histones tail. The tails of histone H3
and H4 have the largest number of potential modification sites
including lysine (K)-specific methylation and acetylation sites and
arginine (R)-specific methylation sites. The tail of histone H3 is subject
to both repressive lysine (K)-specific methylation marks (K9 and K27) as
well as activating lysine (K)-specific methylation marks (K4, K36, and
K79).
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FIGURE 2 | Chromatin state. Cartoon diagram depicting the open
relaxed chromatin of an actively transcribed gene (upper portion),
compared to the nucleosome dense compacted chromatin associated
with a silenced gene (bottom portion). HMT—histone methyltransferase,
HAT—histone acetyltransferase, TBP—TATA-binding protein,
TAF—TBP-associated factors, TF—transcription factor, HDAC—histone
deacetylase, KDM—lysine (K)-specific demethylase, DNMT—DNA
methyltransferase, MBD—methyl-CpG-binding domain.
genes are H3K9me2/3 (promoter and enhancer), H3K27me3
(promoter and enhancer), and H4K20me3 (promoter) (Azuara
et al., 2006; Kolasinska-Zwierz et al., 2009). These common
active and repressive histone marks are further illustrated in
relation to the gene region in which they are detected in
Figure 3.
Studies of histone methylation marks in mouse pluripotent
embryonic stem cells (ESCs) have defined a class of developmen-
tally regulated genes as “bivalent” since these genes are marked
with both active (H3K4me3) and repressive (H3K27me3) histone
modifications (Figure 3; Azuara et al., 2006; Bernstein et al.,
2006; Mikkelsen et al., 2007; Voigt et al., 2013). By exhibiting
both active and repressive features, bivalent genes are posited as
being in a poised state, enabling them to be rapidly activated
upon suitable developmental cues and/or environmental stimuli.
Although bivalent genes were first described for ESCs, where
the marks are most prevalent, later observations also detected
bivalent domains in cell types of restricted potency such as
neural progenitor cells (Mikkelsen et al., 2007; Rugg-Gunn et al.,
2010).
The enzymes responsible for maintaining proper histone
methylation status are histone lysine/arginine methyltrans-
ferases and histone lysine/arginine demethylases. Lysine-specific
histone methyltransferases (HMTs) are subdivided into SET
(Su(var)3–9, Enhancer of Zeste, Trithorax) domain-containing
and non-SET domain-containing proteins. The argine-specific
protein arginine methyltransferases (PRMTs) are responsible
for methylating arginine residues on the histones. HMTs
and PRMTs together have over 60 different family mem-
bers all of which use S-Adenosyl methionine (SAM) as
a cofactor and methyl donor group (Helin and Dhanak,
2013).
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FIGURE 3 | Chromatin modifications are distributed in specific gene
regulatory regions. (A) The normal distribution of DNA methylation,
DNA hydroxymethylation, and histone marks in the enhancer, promoter,
and gene body of actively transcribed genes. Actively transcribed genes
carry typically have chromatin modifications within the gene body to
facilitate transcription initiation and elongation. (B) Common chromatin
modifications found in the enhancer, promoter, and gene body of
silenced genes. (C) Bivalent/poised genes have both activating and
silencing chromatin modifications to facilitate rapid changes in gene
expression during development.
Histone methylation for many years was considered to be a
permanent and irreversible histone modification due to the low
turnover rate of methylated histones (Byvoet et al., 1972). How-
ever, the discovery of lysine specific demethylase 1 (LSD1, offi-
cially known as KDM1A) and later the JmjC-domain-containing
lysine demethylase family has completely changed this view
(Kooistra and Helin, 2012). Interestingly, LSD1 can catalyze the
demethylation of H3K4me1/2 and H3K9me1/2, which means
that LSD1 has the ability to both silence and activate gene tran-
scription (Zhang and Dent, 2005; Wu and Zhang, 2009; Helin
and Dhanak, 2013). LSD1 is also reported to demethylate non-
histone target proteins such as p53, DNMT1, and E2F1 (Huang
et al., 2007; Wang et al., 2009; Kontaki and Talianidis, 2010;
Helin and Dhanak, 2013; Mosammaparast et al., 2013). LSD1 and
its close relative LSD2 belong to the superfamily of flavin ade-
nine dinucleotide (FAD)-dependent monooxidases. Unlike the
LSD demethylases, the JmjC-domain-containing demethylases
can also demethylate trimethylated lysines. This catalysis involves
an oxidative mechanism requiring iron and 2-oxoglutarate as co-
factors and is posited to occur through direct hydroxylation of the
affected methyl group.
HISTONE VARIANTS
Although histones have a conserved role as general DNA packag-
ing agents, it has become clear that another key function of these
proteins is to confer variation in chromatin structure to ensure
dynamic patterns of transcriptional regulation. Some histone
variants have distinct biophysical characteristics that are thought
to alter the properties of nucleosomes, while other variants are
targeted to specific regions of the genome. Specific histone vari-
ants are exchanged with the pre-existing histones during critical
periods of development and differentiation (Brandt et al., 1979;
Grove and Zweidler, 1984; Wunsch et al., 1991; Bosch and Suau,
1995). This replacement can often result in the variants becoming
the predominant species in the differentiated cell (Pina and Suau,
1987; Wunsch et al., 1991). Mutations in specific histone variants
and their associated chaperone machinery contribute to human
disease such as cancer (Maze et al., 2014), suggesting an essential
function for regulation of histone variants during specific aspects
of cellular differentiation.
DNA METHYLATION
Methylation at the 5-positon of cytosine (5-mC) is one of the
best studied and most mechanistically understood epigenetic
modifications that is well conserved among most plant, animal
and fungal models (Feng et al., 2010). Three conserved DNA
methyltransferase enzymes, DNA methyltransferase 1 (DNMT1),
DNMT3A and DNMT3B, are responsible for the deposition and
maintenance of DNA methylation and are essential for normal
development (Li et al., 1992; Okano et al., 1999). Mammalian
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genomes are globally CpG-depleted and roughly 60–80% of the
28 million CpGs in the human genome are generally methylated
(Smith and Meissner, 2013). Less than 10% of CpGs occur in the
CG-dense regions called CpG islands (Deaton and Bird, 2011).
CpG islands are prevalent at transcription start sites (TSSs) of
housekeeping genes and genes involved in developmental pro-
cesses (Deaton and Bird, 2011). Most genomic DNA methyla-
tion patterns are static across tissues and throughout life and
only change in localized contexts as specific cellular processes
are activated or repressed (Figure 3). However, the exception to
this is in the germ line and during pre-implantation embryonic
development, when DNA methylation levels are globally reset
(Smith and Meissner, 2013).
Numerous assays have been developed since DNA methy-
lation was originally postulated as an epigenetic regulator to
study cytosine methylation (Holliday and Pugh, 1975; Riggs,
1975). This includes assays such as methylation-sensitive restric-
tion enzyme mapping, deamination of unmethylated cytosines
with sodium bisulphite, and targeting methylated DNA directly
using antibodies for enrichment. High-throughput sequencing
has enabled complete methylomes to be elucidated, such that
methylation sites are now mapped at base-pair resolution across
development from zygote to terminally differentiated adult cells.
However, global DNA methylation patterns during development
and aging are tissue and cell type-specific (Calvanese et al.,
2012).
DNMT1 is critical for maintaining DNA methylation dur-
ing mitosis. During DNA replication, DNMT1 is positioned at
the replication fork and transfers the methylation marks to the
newly synthesized daughter strand and is essential for stable
repression of genes after cell division. Although DNA methyla-
tion maintenance ensures epigenetic inheritance at established
positions, there are many instances in which methylation must
be specifically targeted and others in which methylation must be
inhibited or removed. DNMT3A and DNMT3B are responsible
for establishing de novo DNA methylation, primarily at CpG
dinucleotides (Jurkowska et al., 2011). DNMT3A and DNMT3B
target promoters in complex with other epigenetic repressors,
including HDACs and repressive HMTs such as EZH2 and G9a.
Additionally, crosstalk exists between some site-specific tran-
scription factors and DNMTs for example DNMT1, DNMT3A,
and DNMT3B have been shown to interact with transcription
factors such as E2F1, E2F6, and Atoh1 to facilitate or prevent
DNA methylation at specific target genes (Robertson et al.,
2000; Bossuyt et al., 2009; Velasco et al., 2010). Loss of all
three DNMTs in ESCs does not affect their survival or stem
cell molecular identity, but the ability to differentiate is com-
pletely inhibited (Jackson et al., 2004; Tsumura et al., 2006).
ESCs lacking DNA methylation fail to up-regulate germ layer
associated markers and are unable to efficiently silence pluripo-
tency genes (Jackson et al., 2004). Typically the transcriptional
network associated with pluripotency is rapidly silenced upon dif-
ferentiation through both maintenance and de novo methylation,
since embryonic programs must be resolved towards specific cell
lineages.
5-mC was initially the only known DNA-specific epigenetic
mark, then in 2009, 5-hydroxymethylcytosine (5-hmC) was
discovered as another relatively abundant cytosine modification
in mouse Purkinje neurons and ESCs (Kriaucionis and Heintz,
2009; Tahiliani et al., 2009). The ten-eleven translocation (TET)
proteins mediate the oxidation of 5-mC to 5-hmC (Tahiliani et al.,
2009; Wang et al., 2012), which is then further oxidized in a step-
wise manner to 5-formylcytosine (5-fC) and 5-carboxylcytosine
(5-caC; He et al., 2011; Ito et al., 2011). An emerging finding is
that 5-mC and 5-hmC are dynamically regulated both within and
across cell types (Kriaucionis and Heintz, 2009; Tahiliani et al.,
2009; Szulwach et al., 2011; Shen and Zhang, 2013). Although
5-hmC may simply act as a DNA demethylation intermediate,
studies have shown that 5-hmC not only impairs the binding
of 5-mC binding proteins (Valinluck et al., 2004), but also
has its own unique binding protein, MBD3, (Yildirim et al.,
2011) and shows unique distribution patterns in the genome
(Stroud et al., 2011; Szulwach et al., 2011). 5-hmC is enriched
in gene dense euchromatic regions, and particularly at TSSs,
promoters, and enhancers (Shen and Zhang, 2013). Addition-
ally, 5-hmC is specifically enriched at gene promoters associated
with bivalent domains marked with both the permissive mark
H3K4me2/3 and the repressive mark H3K27me3, but is absent
from heterochromatin marked by H3K9me3 (Shen and Zhang,
2013).
Recent genome-wide analysis of DNA methylation in human
cells has identified a widespread distribution of 5-mC and, para-
doxically, has shown hypermethylation in the gene bodies of
actively transcribed genes (Figure 3; Lister et al., 2009; Stadler
et al., 2011; Hon et al., 2013; Ziller et al., 2013) and hypomethy-
lation was found at active enhancers (Lister et al., 2009; Stadler
et al., 2011; Hon et al., 2013; Ziller et al., 2013). 5-hmC is also
significantly enriched at distal cis-regulatory sequences, suggest-
ing that dynamic DNA methylation at these regions is likely
mediated by interplays between DNMT mediated methylation
and TET mediated demethylation processes (Stroud et al., 2011;
Szulwach et al., 2011; Yu et al., 2012). Together, these studies
have underscored the diverse roles that DNA methylation has
in gene regulation and the need for systematic mapping and
characterization of DNA methylomes in different tissues and cell
types during development and aging. Since proper maintenance
of 5-mC and 5-hmC by DNMT and TET proteins has been shown
to be critical for proper neurodevelopment and memory (Wang
et al., 2012), aberrant alterations in DNA methylation are also
correlated with diseases such as diabetes, schizophrenia, multiple
sclerosis, cancer, and cellular senescence (Jurkowska et al., 2011).
CHROMATIN REMODELERS
At least three processes control the assembly and regulation of
chromatin: histone modifications, DNA methylation, and ATP-
dependent chromatin remodeling. ATP-dependent chromatin
remodelers alter the physical state of chromatin by either sliding
nucleosomes in relation to the DNA or exchanging nucleosomes
into and out of DNA. Chromatin remodelers act as “readers”
of the histone modifications to regulate chromatin structure
and gene expression. Approximately 30 genes encode the ATP-
dependent chromatin remodeling subunits in mammals. With
few exceptions, the ATP-dependent chromatin remodeling pro-
teins appear to be genetically non-redundant.
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Mutations in ATP-dependent chromatin remodeling genes
often have severe effects on the early embryo or give rise
to maternal-effect phenotypes in which the phenotype of the
embryo reflects the genotype of the mother. In many cases,
the genes encoding the ATP-dependent chromatin remodeling
proteins or their subunits are haploinsufficient, which indicates
that their role in specific developmental processes is likely rate
limiting. For instance, heterozygous mutation in the chromod-
omain helicase DNA binding protein 7 (CHD7) causes CHARGE
syndrome, a multiple anomaly disorder that is a common cause of
deaf-blindness in humans (Zentner et al., 2010), whereas dupli-
cation or overexpression of CHD7 is associated with multiple
forms of cancer including colorectal cancer, pancreatic cancer,
small-cell lung cancer, and gastric cancer (Pleasance et al., 2010;
Kim et al., 2011; Colbert et al., 2014; Tahara et al., 2014). These
data together suggest that many cell types may be highly sen-
sitive to chromatin remodeler dosage during development and
aging.
EPIGENETICS AND HEARING LOSS
Hereditary hearing loss or deafness has been associated with
mutations in genes whose proteins regulate the chromatin state
and include genes involved in DNA methylation, histone mod-
ification and chromatin remodeling (Table 1). Autosomal dom-
inant cerebellar ataxia, deafness, and narcolepsy (ADCADN)
and hereditary sensory neuropathy type IE (HSN1E) are both
caused by heterozygous mutation in the DNMT1 gene (Sun
et al., 2014). ADCADN is characterized by late onset (age 30–
40 years) narcolepsy–cataplexy, sensorineural deafness, cerebellar
ataxia, dementia, psychosis, optic atrophy, and other symptoms
(Winkelmann et al., 2012). Narcolepsy and deafness are typically
the first symptoms to appear followed by ataxia (Winkelmann
et al., 2012). People with HSN1E develop hearing loss that is
caused by abnormalities in the inner ear leading to sensorineural
hearing loss (Wright and Dyck, 1995; Hojo et al., 1999; Klein et al.,
2011). Hearing loss worsens over time and usually progresses
to moderate or severe deafness between the ages of 20 and 35
(Wright and Dyck, 1995; Hojo et al., 1999; Klein et al., 2011).
Mutations in DNMT1 typically cause bilateral hearing loss but
unilateral hearing loss has also been reported (Melberg et al.,
1995).
Mutations in HMT have also been associated with hearing loss.
Overgrowth disorders, Sotos syndrome and Weaver syndrome,
are caused by heterozygous mutations in the HMT NSD1 (Sotos
and Weaver syndromes) and EZH2 (Weaver syndrome) (Tatton-
Brown and Rahman, 2013; Tatton-Brown et al., 2013). Sotos syn-
drome is frequently associated with conductive hearing loss while
only a few cases of hearing loss have been reported for Weaver
syndrome (Tatton-Brown et al., 2013). Although a large degree
of phenotypic overlap exists between Sotos syndrome and Weaver
syndrome, NSD1 and EZH2 regulate different methylation sites.
NSD1 has been shown to preferentially dimethylate H3K36 and
H4K20, the impact of dimethylation at either of these two lysine
residues is not entirely clear at this time (Qiao et al., 2011).
However, EZH2 has been well characterized as it functions as the
catalytic subunit for the polycomb repressive complex 2 (PRC2)
and is a critical regulator of H3K27me3.
Table 1 | Epigenetic factors associated with hearing loss in humans.
Human disease Gene Type of hearing
loss
DNA
methyltransferase
Autosomal dominant cerebellar DNMT1 Sensorineural
ataxia, deafness, and
narcolepsy (ADCADN)
Hereditary sensory neuropathy DNMT1 Sensorineural
type IE (HSN1E)
Histone
methyltransferase
Sotos syndrome NSD1 Conductive
Weaver syndrome EZH2 Conductive
Kleefstra syndrome EHMT1 Sensorineural,
Kabuki syndrome KMT2D Sensorineural
Conductive,
or Mixed
Histone
acetyltransferase
Say-Barber-Biesecker variant KAT6B Sensorineural
of Ohdo syndrome
Genitopatellar syndrome KAT6B Sensorineural
(GPS)
Chromatin
remodeler
CHARGE syndrome CHD7 Sensorineural
Human diseases associated with hereditary hearing loss or deafness caused
by heterozygous mutation in genes whose protein product is involved in DNA
methylation, histone modification, or chromatin remodeling.
Kleefstra syndrome is a developmental disorder character-
ized by intellectual disability, childhood hypotonia, distinctive
facial features and sensorineural hearing loss (Kleefstra et al.,
2005). Heterozygous mutation in euchromatic histone-lysine N-
methyltransferase 1 (EHMT1) is causative for Kleefstra syndrome
(Kleefstra et al., 2005). EHMT1 is part of the E2F6 complex
which represses transcription via methylation of histone H3K9
(Tachibana et al., 2005).
Heterozygous mutation in lysine (K)-specific methyltrans-
ferase 2D (KMT2D, also known as MLL2/MLL4) is associated
with Kabuki syndrome (Ng et al., 2010). Kabuki syndrome is
characterized by distinctive facial features, mild to moderate men-
tal impairment, microcephaly, hypertonia, skeletal abnormalities,
heart abnormalities, and hearing loss (Ng et al., 2010). Hearing
loss is a common finding in Kabuki syndrome and can be con-
ductive, sensorineural or mixed (Barozzi et al., 2009). KMT2D is
a histone methyltransferase that has been shown to mono- and
dimethylate H3K4 (Lee et al., 2013). Approximately 6 percent
of Kabuki syndrome cases are caused by heterozygous mutation
in lysine (K)-specific demethylase 6A (KDM6A). KDM6A cat-
alyzes the demethylation of H3K27me3. Although, KMT2D and
KDM6A have different functions at different lysine residues, both
ultimately act as transcriptional activators (Jiang et al., 2013; Lee
et al., 2013).
Heterozygous mutations in lysine acetyltransferase 6B
(KAT6B, also known as MYST4) are associated with both
genitopatellar syndrome (GPS) and Say-Barber-Biesecker
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variant of Ohdo syndrome (Campeau et al., 2012a; Simpson
et al., 2012). These KAT6B-related disorders have phenotypic
overlap that includes significant global developmental
delay/intellectual disability, hypotonia, cryptorchidism,
patellar hypoplasia/agenesis, congenital heart defects, dental
anomalies, hearing loss, and thyroid anomalies (Campeau et al.,
2012a; Simpson et al., 2012). KAT6B is a HAT that also has
transcriptional activation activity in the N-terminal end of the
protein and transcriptional repression activity in the C-terminal
end of the protein (Campeau et al., 2012b). Mutations leading
to GPS occur in the proximal portion of the last exon and lead
to the expression of a protein without a C-terminal domain,
while mutations leading to Say-Barber-Biesecker variant of Ohdo
syndrome occur either throughout the gene, leading to nonsense-
mediated decay, or more distally in the last exon (Campeau et al.,
2012b).
CHD7 has been more extensively characterized in regards to
inner ear development than the epigenetic factors listed above.
CHD7 haploinsufficiency causes CHARGE syndrome, the most
consistent clinical feature associated with CHARGE is inner
ear defects, including semicircular canal dysplasia that typically
affects all three canals, and a Mondini form of cochlear hypoplasia
(Layman et al., 2010; Zentner et al., 2010). Inner ear phenotypes
observed in mouse models of CHARGE syndrome are similar
to those reported in CHARGE patients and include semicircular
canal defects, innervation defects, and vestibular dysfunction
(Kiernan et al., 2002; Hawker et al., 2005; Adams et al., 2007; Hurd
et al., 2007). Complete absence of CHD7 results in decreased
expression of patterning and pro-neural genes including Otx2,
Fgf10, Ngn1, NeuroD, Islet1, Rarb, and Rxrg genes leading to
reduced proliferation of developing neuroblasts and inner ear
malformations (Hurd et al., 2010; Micucci et al., 2014). Addi-
tionally, a recent report found that CHD7 deficiency triggers both
p53 expression and activation (Van Nostrand et al., 2014). These
data together provide a basis for understanding how CHD7 defi-
ciency results in the profound yet variable phenotypes associated
with CHARGE syndrome and potential targets for therapeutic
development.
EPIGENETICS: DAMAGE AND PROTECTION
Auditory hair cells have repeatedly been shown to be susceptible
to ototoxicity from a multitude of drugs including aminogly-
coside antibiotics such as gentamicin, loop diuretics such as
furosemide, platinum-based chemotherapy agents such as cis-
platin, and a number of non-steroidal anti-inflammatory drugs
(NSAIDS). Additionally, noise is one of the most common causes
of hearing loss, and one of the most common occupational
illnesses in the United States. The formation of reactive oxygen
species (ROS) is the major cause that underlies the molecular
pathology of hair cell death related to noise induced trauma as
well as aminoglycoside antibiotic and cisplatin treatment (Cheng
et al., 2005; Schacht et al., 2012). ROS production is associated
with increased DNA damage and chromosomal degradation with
alterations of both hypermethylation and hypomethylation of the
DNA (Campos et al., 2007; Lim et al., 2008; Donkena et al.,
2010; Ziech et al., 2010, 2011). Aminoglycoside antibiotics have
also been shown to cause increased histone deacetylation in
mammalian hair cells through recruitment of HDACs to the
chromatin (Jiang et al., 2006; Chen et al., 2009).
HDAC inhibitors were originally used as anti-cancer agents
and some are approved by the FDA for use in the treatment of
specific types of cancer in humans. However, broad spectrum
and HDAC-specific inhibitors are also known to have protective
effects in a concentration dependent manner in inflammation,
neurodegeneration, and oxidative stress models (Ryu et al., 2003;
Liu et al., 2012a; Robert and Rassool, 2012). HDAC inhibitors are
primarily thought to modulate chromatin condensation by regu-
lating histone acetylation and thus affect gene expression. HDAC
inhibitors have also been shown to affect the post-translational
modification of some important intracellular non-histone pro-
teins, such as heat shock protein 90 and Rel-A/p65 (Yu et al., 2002;
Faraco et al., 2009). In the inner ear, HDAC inhibitors also have
a protective effect on hair cells subjected to aminoglycosides in
vitro (Chen et al., 2009) and cisplatin in vivo (Drottar et al., 2006).
However, the precise mechanism underlying their protective effect
in the inner ear remains unknown.
CELLULAR REPROGRAMMING AND HAIR CELL
REGENERATION
Reprogramming cell fate through transcription factor(s) over-
expression is a general and powerful approach for regenerative
medicine (Cohen and Melton, 2011). However, direct reprogram-
ming through ectopic expression of defined transcription factors
is a slow and inefficient process that requires weeks, with most
cells failing to reprogram (Huangfu et al., 2008; Mikkelsen et al.,
2008). Additionally, the efficiency and yield of cellular repro-
gramming rapidly declines with increasing age and differentiation
status of the donor cell (Hanna et al., 2010; Kim et al., 2010;
Lister et al., 2011). A large reconfiguration of the chromatin
structure, from DNA methylation to histone modifications and
nucleosome remodeling, occurs during somatic cell reprogram-
ming to a pluripotent state. These layers of epigenetic regula-
tion are often used as repressive mechanisms in somatic cells
to prevent unwanted gene expression from other lineages. How
these epigenetic barriers to reprogramming are overcome is a key
question, since the epigenetic memory of the somatic cell largely
impacts its capacity for cellular reprogramming. Several lines of
evidence support the notion that the process of reprogramming
involves rare stochastic epigenetic events. Studies have shown that
inhibitors of epigenetic events such as DNA methylation, histone
deacetylation, and histone methylation are able to improve repro-
gramming efficiency (Huangfu et al., 2008; Mikkelsen et al., 2008;
Hanna et al., 2010; Kim et al., 2010; Lister et al., 2011).
The epigenetic modifications made during inner ear develop-
ment remain mostly unknown at this time. However, cofactors of
repressive complexes such as NuRD and PRC2 have been reported
to be present in the neonatal mouse organ of Corti. The NuRD
cofactors including LSD1 are present throughout most of the
organ of Corti from E18.5 until P4, then completely absent by
P7, and are detectable again from P8 through P21 (Layman et al.,
2013). The PRC2 enzymatic subunit, EZH2 is also highly present
from E18.5 to P0 in the mouse organ of Corti, absent between
P2 and P4, and is evident again throughout the organ of Corti by
P6 and persists through P21 (Layman et al., 2013). The presence
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of these repressive complexes also correlates with transcriptional
silencing of known target genes of LSD1 and EZH2 including
genes required for proliferation (mTert) and cell fate specification
(Atoh1), which is consistent with reports related to organ of
Corti quiescence and maturation during neonatal development.
Additionally, DNMT3A and DNMT3B are also reported to have
a dramatic increase in expression after the first postnatal week
in the mouse organ of Corti (Mutai et al., 2009; Layman et al.,
2013). DNA methylation is one of the most common and irre-
versible epigenetic modifications that control gene expression.
DNA methylation may repress genes encoding drug metabolizing
enzymes, drug transporters, or even drug target genes, which may
alter the pharmacokinetics and pharmacodynamics of drugs that
may be ototoxic or drugs designed to facilitate hearing regenera-
tion. A better understanding of how the genes in the inner ear are
regulated epigenetically will allow researchers the ability to design
therapeutic agents that may bypass or alter the chromatin state
making it more amenable to cellular reprogramming.
Unlike mammalian hair cells, hair cells in the avian basilar
papilla and utricle are rapidly regenerated after ototoxic injury
(Corwin and Oberholtzer, 1997). New avian hair cells are gen-
erated from the epithelial supporting cells through renewed sup-
porting cell proliferation and by direct cellular conversion from
a supporting cell to a hair cell (Raphael, 1992; Weisleder and
Rubel, 1993; Roberson et al., 2004). However, pharmacological
inhibition of HDACs results in decreased proliferation of avian
vestibular supporting cells, both in dissociated culture and in
intact utricles (Slattery et al., 2009). The reduction in supporting
cell proliferation causes a reduction in the number of regenerated
hair cells but does not directly affect hair cell differentiation
(Slattery et al., 2009). These data indicate that HDACs have a
critical function in regulating gene expression in non-sensory
epithelial cells responding to ototoxic insult during normal regen-
erative processes. Further analysis is needed to determine which
genes are being regulated by HDACs and whether each specific
gene is critical for the proliferative response in supporting cells.
Naturally regenerating systems such as the avian basilar papilla
and utricle provide much needed information about the regula-
tory networks that are required for hair cell regeneration. Ideally,
a comparison of the DNA methylome and histone modifications
between the naturally regenerating system and the mammalian
system following ototoxic insult would provide vital information
about the types of epigenetic events that must occur to achieve
complete mammalian hair cell regeneration.
The cell type specific distribution of histone modifications,
DNA methylation, and chromatin remodeling events needs to
be characterized during inner ear development from a multi-
potent progenitor cell to a terminally differentiated cell. The
mammalian inner ear offers unique challenges for evaluating the
epigenome given the limited number of cells across a diversity
of cell types. Transcriptomic analysis of the mammalian inner
ear during development by microarray or RNA-seq may provide
a starting point for analyzing epigenetic modifications that may
regulate the expression of specific target genes and microRNAs
(Elkan-Miller et al., 2011; Smeti et al., 2012; Rudnicki et al.,
2014). Emerging evidence has shown that more than one hundred
microRNAs are regulated by epigenetic mechanisms, and about
50% of them are modulated by DNA methylation (Saito et al.,
2006; Kunej et al., 2011; Suzuki et al., 2011). Additionally, a
subgroup of microRNAs has been shown to directly target the
enzymatic effectors of epigenetic modifications, which adds more
complexity to the epigenetic regulatory network (Garzon et al.,
2009; Iorio et al., 2010).
CONCLUSIONS
Given that epigenetics is a cornerstone of development and cellu-
lar reprogramming, it seems likely that understanding and manip-
ulating the epigenome holds enormous promise for preventing
and treating hearing loss in humans. Epigenetics also offers an
important window to understanding how ototoxic compounds
and noise affect gene regulatory networks and how these epige-
netic modifications may be manipulated and overcome utilizing
epigenetic therapeutics. Understanding epigenetic mechanisms
has become a major focus for research in most biological systems.
The field of hearing research could greatly benefit from the vast
amounts of information that can be garnered from epigenetic
work in other biological systems to gain a better understanding
of the complex gene regulatory networks being regulated in the
inner ear.
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